Sintx Technologies (NASDAQ:SINT) Stock Price Down 2% – Here’s What Happened

Sintx Technologies, Inc. (NASDAQ:SINT) traded down 2% on Tuesday . The company traded as low as $2.85 and last traded at $2.88. 16,961 shares were traded during mid-day trading, a decline of 45% from the average session volume of 30,683 shares. The stock had previously closed at $2.94.

Analyst Upgrades and Downgrades

SINT has been the topic of a number of analyst reports. Ascendiant Capital Markets reduced their price target on Sintx Technologies from $25.00 to $16.00 and set a “buy” rating on the stock in a research report on Monday, December 8th. Wall Street Zen downgraded shares of Sintx Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $16.00.

Sintx Technologies Trading Down 2.0%

The company has a market cap of $10.60 million, a price-to-earnings ratio of -0.51 and a beta of 0.70. The stock’s 50-day moving average is $3.59 and its 200-day moving average is $3.67.

Sintx Technologies (NASDAQ:SINT) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($3.46) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($2.91). Sintx Technologies had a negative return on equity of 218.25% and a negative net margin of 775.12%.The company had revenue of $0.21 million during the quarter, compared to analyst estimates of $0.20 million.

Insider Activity at Sintx Technologies

In other news, CIO Gregg R. Honigblum bought 8,200 shares of the firm’s stock in a transaction that occurred on Monday, December 8th. The stock was acquired at an average cost of $4.26 per share, with a total value of $34,932.00. Following the transaction, the executive directly owned 201,067 shares of the company’s stock, valued at approximately $856,545.42. This represents a 4.25% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.08% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Sintx Technologies

Several hedge funds and other institutional investors have recently made changes to their positions in SINT. Geode Capital Management LLC lifted its holdings in shares of Sintx Technologies by 33.5% in the second quarter. Geode Capital Management LLC now owns 15,339 shares of the company’s stock valued at $49,000 after purchasing an additional 3,848 shares in the last quarter. Veracity Capital LLC lifted its position in shares of Sintx Technologies by 10.3% during the 3rd quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock worth $327,000 after buying an additional 7,464 shares in the last quarter. Finally, Virtus Wealth Solutions LLC bought a new position in shares of Sintx Technologies during the 3rd quarter worth approximately $388,000. 18.38% of the stock is owned by institutional investors.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.